CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

promising biotech

  1. 13,386 Posts.
    lightbulb Created with Sketch. 162
    Oncology company Chemgenex Pharmaceuticals (CXS) is also on track again with the FDA. The company is expected to resubmit its new drug application in the first half of 2011 for Omapro, for the treatment of chronic myeloid leukaemia




    http://www.asx.com.au/resources/newsletters/investor_update/20110111_9_promising_biotechs.htm
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.